drugset / Trial / NCT01205009

Human Chorionic Gonadotropin Supplementation Prior to In-vitro Fertilization Treatment in Poor Responders

NCT01205009

Unknown 100 enrolled Hadassah Medical Organization
RandomizedParallel-groupOpen-labelTreatment

Summary

In an era of delayed fertility plans, there is increasing need for fertility treatment in older women with poor response. Human chorionic gonadotropin (hCG) supplementation prior to treatment, as a thecal stimulant, may improve folliculogenesis and ovarian response.

Timeline

Start
2011-04
Primary completion
2012-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ovidrel Protein / enzyme biologic 250 ug

Indications